Form 4: Incyte Director Edmund Harrigan Acquires Shares in Lieu of Retainer Fees

Director Edmund Harrigan acquired 409 shares of Incyte Corp common stock on June 28, 2024, in lieu of quarterly director retainer fees.

Summary

• On June 28, 2024, Edmund Harrigan, a director of Incyte Corp, acquired 409 shares of common stock.
• The acquisition was made in lieu of quarterly director retainer fees under the company's Amended and Restated 2010 Stock Incentive Plan.
• The price per share was $60.62.
• Following the transaction, Harrigan beneficially owns 16,354 shares of Incyte Corp common stock, which includes 2,830 unvested restricted stock units.
• The transaction was conducted under a Rule 10b5-1 plan.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's acceptance of stock in lieu of cash suggests confidence in the company's prospects. The transaction is part of a pre-arranged plan, reducing uncertainty.

Positives

• The director's decision to take shares in lieu of cash compensation demonstrates confidence in the company's future performance.
• The transaction was executed under a pre-arranged Rule 10b5-1 plan, indicating transparency and avoiding concerns about insider trading.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This type of transaction, where directors receive stock in lieu of cash compensation, is relatively common in the pharmaceutical industry and can align the interests of management with those of shareholders.

Comparison to Industry Standards

• Many pharmaceutical companies use stock-based compensation to attract and retain talent, aligning executive incentives with shareholder value.
• Companies like Regeneron and Vertex Pharmaceuticals also utilize stock options and restricted stock units as part of their compensation packages for directors and executives.
• The specific amount and terms of these arrangements vary based on company size, performance, and industry benchmarks.

Related Party Transactions

• The acquisition of shares by Edmund Harrigan in lieu of director retainer fees is a related party transaction.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Key Dates